- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05354518
Teaching Method With Simulation in Gestational Diabetes Mellitus Management
April 23, 2022 updated by: Esra Yılmaz, Saglik Bilimleri Universitesi
Evaluation of the Effectiveness of Teaching Method With Simulation in Gestational Diabetes Mellitus Management
Gestational Diabetes Mellitus is one of the common risk factors of pregnancy and occurs for the first time during pregnancy.
It adversely affects maternal and fetal health and causes an increase in morbidity and mortality rates.
In this context, it is very important to identify possible risks for GDM, plan, implement and evaluate initiatives, provide emergency crisis management in a short time without damage, and increase the self-confidence of midwives.
In recent years, interest in simulation methods and skill acquisition training in midwifery education has increased.
Research; In the management of GDM, to increase the satisfaction and self-confidence level of midwifery students in learning, to evaluate the simulation design and educational effectiveness, it was planned to use the scenario-based near-realistic simulation method in the form of randomized control-intervention quantitatively, and in qualitative design to evaluate the students' views on the method and educational effectiveness.
The research will make it easier for midwifery students to intervene with the patient in a shorter time, with confidence and with sufficient clinical skills, and patient safety will be increased.
In addition, it will allow the reduction of erroneous clinical practices and malpractices.
This study aims to evaluate the satisfaction and self-confidence status of midwifery students and the educational effectiveness of the scenario-based simulation method with high closeness to reality in GDM management and to examine the opinions about this method to fill the gap in the literature.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Esra YILMAZ
- Phone Number: +905072025738
- Email: esrayilmaz939@gmail.com
Study Contact Backup
- Name: Besey Oren
- Phone Number: +905327756206
- Email: Besey.oren@sbu.edu.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Agreeing to participate in the research,
- Being a midwifery 3rd year student and taking the "risky pregnancy" course,
- Those who have no previous clinical experience in GDM (Health College, Health Vocational High School Graduate, etc.)
Exclusion Criteria:
- To fill in the data collection forms of the study incompletely,
- Not participating in all applications of simulation training with high proximity to reality,
- Desire to leave the research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: gestational diabetes management simulation
|
Gestational diabetes management of midwifery students with a simulator
|
|
No Intervention: no intervention will be made
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
information evaluation form
Time Frame: immediately before simulation
|
The information evaluation form is in a multiple-choice format consisting of 25 questions by scanning the literature by the researchers.
Each question is worth 4 points.
|
immediately before simulation
|
|
information evaluation form
Time Frame: 7 weeks after the first simulation application
|
The information evaluation form is in a multiple-choice format consisting of 25 questions by scanning the literature by the researchers.
Each question is worth 4 points.
|
7 weeks after the first simulation application
|
|
Student Satisfaction and Self-Confidence Scale in Learning
Time Frame: immediately after the first simulation application
|
The scale is a 13-item measurement tool designed to measure student satisfaction with simulation and self-confidence during practices.
It is a 5-point Likert type and is scored as strongly disagree 1, disagree 2, undecided 3, agree 4, strongly agree 5.
|
immediately after the first simulation application
|
|
Student Satisfaction and Self-Confidence Scale in Learning
Time Frame: immediately after the second simulation application
|
The scale is a 13-item measurement tool designed to measure student satisfaction with simulation and self-confidence during practices.
It is a 5-point Likert type and is scored as strongly disagree 1, disagree 2, undecided 3, agree 4, strongly agree 5.
|
immediately after the second simulation application
|
|
Student Satisfaction and Self-Confidence Scale in Learning
Time Frame: immediately after the third simulation application
|
The scale is a 13-item measurement tool designed to measure student satisfaction with simulation and self-confidence during practices.
It is a 5-point Likert type and is scored as strongly disagree 1, disagree 2, undecided 3, agree 4, strongly agree 5.
|
immediately after the third simulation application
|
|
Simulation Design Scale
Time Frame: immediately after the first simulation application
|
The simulation method applied and designed to the intervention group is used in the evaluation of the participants.
The simulation design scale consists of 20 items in total.
Evaluation of the scale is done in two stages.
In the first stage, in order to evaluate whether the items used in the simulation method were given in the best way for the participant, they were expressed as strongly disagree, disagree, undecided, agree, strongly agree.
In the second stage, there are statements that will determine the level of importance of the scale items for the participant, not important, partially important, undecided, important, very important.
In the evaluation phase, the scale score is calculated by dividing the total and the total of the sub-dimensions by the number of items.
|
immediately after the first simulation application
|
|
Simulation Design Scale
Time Frame: immediately after the second simulation application
|
The simulation method applied and designed to the intervention group is used in the evaluation of the participants.
The simulation design scale consists of 20 items in total.
Evaluation of the scale is done in two stages.
In the first stage, in order to evaluate whether the items used in the simulation method were given in the best way for the participant, they were expressed as strongly disagree, disagree, undecided, agree, strongly agree.
In the second stage, there are statements that will determine the level of importance of the scale items for the participant, not important, partially important, undecided, important, very important.
In the evaluation phase, the scale score is calculated by dividing the total and the total of the sub-dimensions by the number of items.
|
immediately after the second simulation application
|
|
Simulation Design Scale
Time Frame: immediately after the third simulation application
|
The simulation method applied and designed to the intervention group is used in the evaluation of the participants.
The simulation design scale consists of 20 items in total.
Evaluation of the scale is done in two stages.
In the first stage, in order to evaluate whether the items used in the simulation method were given in the best way for the participant, they were expressed as strongly disagree, disagree, undecided, agree, strongly agree.
In the second stage, there are statements that will determine the level of importance of the scale items for the participant, not important, partially important, undecided, important, very important.
In the evaluation phase, the scale score is calculated by dividing the total and the total of the sub-dimensions by the number of items.
|
immediately after the third simulation application
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Semi-Structured Focus Group Training Activity Evaluation Form
Time Frame: 7 weeks after starting the study
|
It is a form consisting of 5 semi-structured questions created by the researchers after a comprehensive literature search in order to evaluate the simulation training effectiveness.
With these questions, it was aimed to determine the strengths and weaknesses of training with the simulation method regarding GDM management, the opportunities/opportunities it provides and the threats and dangers created by this method.
|
7 weeks after starting the study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 19, 2022
Primary Completion (Anticipated)
April 19, 2022
Study Completion (Anticipated)
May 31, 2024
Study Registration Dates
First Submitted
April 17, 2022
First Submitted That Met QC Criteria
April 23, 2022
First Posted (Actual)
April 29, 2022
Study Record Updates
Last Update Posted (Actual)
April 29, 2022
Last Update Submitted That Met QC Criteria
April 23, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- sbu_yılmaz38
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes, Gestational
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Royal College of Surgeons, IrelandHealth Research Board - Trials Methodology Research NetworkCompletedPre-Gestational DiabetesIreland
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
University of Tennessee Graduate School of MedicineRecruitingInsulin Resistance | Pregnancy Complications | Pregnancy | Preeclampsia | Gestational Diabetes | Gestational Diabetes Mellitus in Pregnancy | Placental Dysfunction | Gestational Diabetes Mellitus (GDM) | Preeclampsia (PE) | Cardiometabolic Diseases | Gestational Complications | Preeclampsia (PE) RiskUnited States
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingPregnancy Complications | Gestational Diabetes Mellitus (GDM) | Diabetes During Pregnancy | Pregnancy in Diabetes | Gestational | Diabetes ComplicationPakistan
-
Baylor College of MedicineRecruitingGestational Diabetes MellitusUnited States
Clinical Trials on gestational diabetes management of midwifery students
-
Corporacion Parc TauliTechnical University of Madrid; CIBER-BBN: Networking Research Center for Bioengineering...Completed
-
Kahramanmaras Sutcu Imam UniversityNot yet recruitingClinical Skills Training | Midwifery Education
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiagnoses Disease | Gestational Diabetes | Glucose, High Blood | Pregnancy in DiabeticUnited States
-
Hospices Civils de LyonCompletedOral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)Gestational DiabetesFrance
-
California Polytechnic State University-San Luis...CompletedA Pilot Study Using Weightloss and Exercise to Prevent Recurring Gestational Diabetes in Obese WomenGestational DiabetesUnited States
-
Cukurova UniversityCompletedQuality of Life | Motivational Interviewing | Self Efficacy | Gestational Diabetes MellitusTurkey (Türkiye)
-
Yale UniversityNational Institute on Minority Health and Health Disparities (NIMHD)CompletedDiabetes Mellitus, Type 2 | Patient EducationUnited States
-
Purbanchal UniversityCompleted
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingDiabetes Type 2 | Gestational Diabetes Mellitus (GDM) | Breastfeeding Support | Breastfeeding ContinuationUnited States
-
Singapore Institute for Clinical SciencesNational University Polyclinics, Singapore; National University of SingaporeCompletedHealthy | Diabetes, Gestational | Gestational Diabetes Mellitus in PregnancySingapore